Drug intelligence / Profile preview

CobiMax

Development stage
Unknown
Lead developer
Parnasa Mediworld
Modality
Small Molecules
Administration
Oral
01

Overview

CobiMax is a nutritional supplement developed by Parnasa Mediworld, formulated as a soft gelatin capsule for oral administration. It contains a combination of omega-3 fatty acids (specifically eicosapentaenoic acid and docosahexaenoic acid), coenzyme Q10, lycopene, and selenium. This combination is typically used to support cardiovascular health, provide antioxidant protection, and address nutritional deficiencies. Omega-3 fatty acids contribute to heart health and anti-inflammatory processes, coenzyme Q10 is essential for mitochondrial energy production, lycopene is a potent carotenoid antioxidant, and selenium is a trace mineral that acts as a cofactor for antioxidant enzymes like glutathione peroxidase.

Brand names
CobiMax
Other names
Omega-3-Fatty Acids + Coenzyme Q10 + Lycopene + Selenium
02

Targets

ND1 (Mitochondrial electron transport chain complex I)GPX4 (Glutathione peroxidase 4)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on CobiMax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CobiMax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call